Regarding: "The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial".

Nakata, Takeshi; Ariie, Takashi; Taito, Shunsuke

Nakata, Takeshi; Ariie, Takashi; Taito, Shunsuke.

Afiliación

Nakata T; Department of Endocrinology Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi Yufu, Oita, 879-5593, Japan. nakata@oita-u.ac.jp.
Ariie T; Systematic Review Workshop Peer Support Group (SRWS-PSG), Osaka, Japan. nakata@oita-u.ac.jp.
Taito S; Department of Physical Therapy, School of Health Sciences at Fukuoka, International University of Health and Welfare, 137-1 Enokizu, Okawa-shi, Fukuoka, 831-8501, Japan.

J Transl Med ; 19(1): 282, 2021 06 30.

Article en En | MEDLINE | ID: mdl-34193209

Asunto(s)

COVID-19; Ácidos Grasos Omega-3; Enfermedad Crítica; Suplementos Dietéticos; Método Doble Ciego; Ácidos Grasos Omega-3/uso terapéutico; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácidos Grasos Omega-3 / COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Transl Med Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google